Agilent Technologies A is preparing to launch its quarterly incomes on Monday, 2024-11-25. Here’s a quick summary of what financiers ought to bear in mind before the statement.
Experts anticipate Agilent Technologies to report an incomes per share (EPS) of $1.40.
Financiers in Agilent Technologies are excitedly waiting for the business’s statement, expecting news of exceeding quotes and favorable assistance for the next quarter.
It deserves keeping in mind for brand-new financiers that stock rates can be greatly affected by future forecasts instead of simply previous efficiency.
Incomes Performance History
Last quarter the business beat EPS by $0.06, which was followed by a 0.16% boost in the share rate the next day.
Here’s a take a look at Agilent Technologies’s previous efficiency and the resulting rate modification:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Price Quote | 1.26 | 1.19 | 1.22 | 1.35 |
| EPS Actual | 1.32 | 1.22 | 1.29 | 1.38 |
| Cost Modification % | 0.0% | -10.0% | 3.0% | 9.0% |
Market Efficiency of Agilent Technologies’s Stock
Shares of Agilent Technologies were trading at $132.06 since November 21. Over the last 52-week duration, shares are up 5.86%. Considered that these returns are normally favorable, long-lasting investors ought to be pleased entering into this incomes release.
Expert Observations about Agilent Technologies
Comprehending market beliefs and expectations within the market is essential for financiers. This analysis looks into the most recent insights on Agilent Technologies.
Experts have actually offered Agilent Technologies with 3 rankings, leading to an agreement score of Neutral. The typical 1 year rate target stands at $149.0, recommending a prospective 12.83% advantage.
Comparing Rankings Amongst Market Peers
In this analysis, we look into the expert rankings and typical 1-year rate targets of IQVIA Hldgs, Waters and Illumina, 3 crucial market gamers, providing insights into their relative efficiency expectations and market positioning.
- The dominating belief amongst experts is an Outperform trajectory for IQVIA Hldgs, with a typical 1-year rate target of $261.21, indicating a prospective 97.8% advantage.
- The dominating belief amongst experts is an Neutral trajectory for Waters, with a typical 1-year rate target of $370.0, indicating a prospective 180.18% advantage.
- For Illumina, experts forecast an Neutral trajectory, with a typical 1-year rate target of $173.56, showing a prospective 31.43% advantage.
Summary of Peers Analysis
The peer analysis summary offers a photo of crucial metrics for IQVIA Hldgs, Waters and Illumina, brightening their particular standings within the market. These metrics provide important insights into their market positions and relative efficiency.
| Business | Agreement | Earnings Development | Gross Earnings | Return on Equity |
|---|---|---|---|---|
| Agilent Technologies | Neutral | -5.62% | $ 855M | 4.65% |
| IQVIA Hldgs | Outperform | 4.28% | $ 1.38 B | 4.17% |
| Waters | Neutral | 4.02% | $ 438.65 M | 10.71% |
| Illumina | Neutral | -3.49% | $ 745M | 39.60% |
Secret Takeaway:
Agilent Technologies ranks in the middle amongst peers for Agreement score. It is at the bottom for Earnings Development. For Gross Earnings, it is at the top. In regards to Return on Equity, Agilent Technologies is at the bottom compared to its peers.
Exploring Agilent Technologies’s Background
Initially drew out of Hewlett-Packard in 1999, Agilent has actually progressed into a leading life science and diagnostic company. Today, Agilent’s measurement innovations serve a broad base of consumers with its 3 operating sectors: life science and used tools, cross laboratory including consumables and services associated with life science and used tools, and diagnostics and genomics. Over half of its sales are produced from the biopharmaceutical, chemical, and advanced products end markets, which we consider as the stickiest end markets, however it likewise supports medical laboratory, ecological, forensics, food, scholastic, and government-related companies. The business is geographically varied, with operations in the United States and China representing the biggest nation concentrations.
Agilent Technologies: A Financial Summary
Market Capitalization: Placed above market average, the business’s market capitalization highlights its supremacy in size, a sign of a strong market existence.
Earnings Development: Agilent Technologies’s income development over a duration of 3 months has actually dealt with obstacles. Since 31 July, 2024, the business experienced an income decrease of roughly -5.62% This suggests a reduction in the business’s top-line incomes. As compared to rivals, the business came across troubles, with a development rate lower than the average amongst peers in the Healthcare sector.
Net Margin: Agilent Technologies’s net margin stands out beyond market criteria, reaching 17.87% This represents effective expense management and strong monetary health.
Return on Equity (ROE): Agilent Technologies’s ROE stands apart, exceeding market averages. With a remarkable ROE of 4.65%, the business shows efficient usage of equity capital and strong monetary efficiency.
Return on Possessions (ROA): Agilent Technologies’s monetary strength is shown in its remarkable ROA, which surpasses market averages. With an amazing ROA of 2.58%, the business showcases effective usage of properties and strong monetary health.
Financial Obligation Management: With a below-average debt-to-equity ratio of 0.5, Agilent Technologies embraces a sensible monetary method, showing a well balanced technique to financial obligation management.
To track all incomes releases for Agilent Technologies visit their incomes calendar on our website.
This post was produced by Benzinga’s automatic material engine and examined by an editor.
© 2024 Benzinga.com. Benzinga does not offer financial investment recommendations. All rights booked.